FDA Alerts

After several studies demonstrated its efficacy, the FDA expanded the approval of the DigniCap Cooling System to prevent hair loss during chemotherapy to other cancer patients.

The FDA has approved a new option for the treatment of central precocious puberty.

The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...

The FDA has approved a new treatment option for the prophylaxis of venous thromboembolism in hospitalized patients.

After a multicenter trial demonstrated its efficacy, the US Food and Drug Administration approved a subcutaneous option for the treatment of hereditary angioedema.

The US Food and Drug Administration has approved the first treatment for a genetic mutation of non-small cell lung cancer, and also approved the diagnostic test for determining multiple genetic mutations...

The US Food and Drug Administration has approved a combination intravenous treatment for follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.

The FDA has approved a new option for the treatment of adolescents and adults with ADHD.

A new drug found to be effective against gram-positive and gram-negative pathogens, including MRSA, has been approved by the FDA.

The US Food and Drug Administration has approved an immunotherapy with the first CD38-directed antibody to be approved in any country.